The Exploration of Pan-Cancer Dysregulated Pathways and PolyTherapy AI
The August NCI Cancer Research Data Commons (CRDC) Cancer Genomics Cloud (CGC) webinar will feature a presentation from bioinformatics consultant and CGC Collaborative Project Award recipient Margaret Liñán. She will share how her work with the Arizona State’s Translational Genomics Lab leveraged the CGC’s cloud-based access to perform pan-cancer studies.
During the event, Ms. Liñán will discuss her collaboration’s current and pan-cancer research study efforts, including:
- the detection and ranking of mRNA dysregulated pathways using the Pathways of Topological Rank Analysis (PoTRA) tool with normalized TCGA data from the CGC.
- the identification of rank dispersion drivers in mRNA mediated dysregulated pathways from invasive breast cancer
- the development of an interactive artificial intelligence platform, PolyTherapy AI, for multi-omics combination drug treatment.
As one of the three Cloud Resources within the NCI CRDC, the Seven Bridges’ CGC provides researchers access to a wide variety of data sets, a catalog of tools to analyze and visualize the data directly from the browser, and scalable computational resources to perform large-scale analysis on the cloud.
Ms. Liñán is a bioinformatics consultant currently collaborating with Dr. Valentin Dinu’s Translational Genomics Lab at the College of Health Solutions – Arizona State University and others in academia and industry.
- Cancer Research Data Commons and Other NCI Infrastructures in Support of Data ScienceSeptember 19, 2021AttentiveChrome: Deep-learning for Predicting Gene Expression from Histone ModificationsSeptember 22, 2021“Le Grand et Le Petit”: Splicing Factors SF3B1 and SUGP1 and Their Cancer Mutations Leading to Aberrant Acceptor UsageSeptember 22, 2021The Future of Clinical Trial Data Sharing.... The Art of The PossibleSeptember 23, 2021Genomic Data Commons Single Cell RNA-Seq SupportSeptember 27, 2021Virtual Workshop on Next-Generation Sequencing and Radiomics: Resource Requirements for Acceleration of Clinical Applications Including AISeptember 29, 2021 - September 30, 2021